A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cefadroxil Impurity 2 - Request Quote

Picture of Cefadroxil Impurity 2

Cefadroxil Impurity 2

SZ CAT No:SZ-C061042
CAS No
NA
Mol.F.
C19H21N3O7S
Mol.Wt.
435.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Cefadroxil Impurity 2 is chemically (6R,7R)-7-((R)-2-Amino-2-(4-((ethoxycarbonyl)oxy)phenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid. Cefadroxil Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Cefadroxil Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefadroxil.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Cefadroxil Impurity 2

Purchase Cefadroxil Impurity 2

Cefadroxil Impurity 2 suppliers

Cefadroxil Impurity 2 manufacturers

Cefadroxil Impurity 2 price

Order Cefadroxil Impurity 2

Enquire Cefadroxil Impurity 2

Cefadroxil Impurity 2 cost

Cefadroxil Impurity 2 Supplier

Cefadroxil Impurity 2 Distributor

Cefadroxil Impurity 2 for Method Validation

Cefadroxil Reference Standard

Cefadroxil Impurity 2 for ANDA Filing

Cefadroxil Impurity 2 for Forced Degradation Studies

Cefadroxil Impurity 2 Identification Standards

Cefadroxil Impurity 2 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,